Clinical Supply Regulatory Articles

  1. From Policy To Practice: Embedding Export Compliance In Clinical Supply 4/13/2026

    Export compliance in clinical supply cannot be an afterthought. Embedding it into workflows, training, and decision making reduces risk while improving speed and coordination.

  2. Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials 4/8/2026

    Decentralized trials promise better patient access but create major supply risks. From cold chain failures to regulatory hurdles, here is what sponsors must solve now.

  3. R&D Capitalization Decisions That Drive Clinical Trial Supply 4/1/2026

    R&D capitalization changes are reshaping trial funding. The real impact hits clinical supply, where tax strategy now directly influences timelines, inventory, and execution.

  4. The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early 3/30/2026

    Clinical trial supply chains face a 2033 NDC-12 deadline; early action on product identity, labeling, and data governance can prevent costly disruptions and misalignment.

  5. Drug Shortages In Clinical Trials: A Policy Blueprint 3/26/2026

    Clinical trial drug shortages are a silent crisis threatening patient safety, trial integrity, and costs. Practical policy reforms and risk planning can prevent disruption.

  6. How Clinical Supply Teams Can Prevent Cross-Border Shipping Delays 3/23/2026

    Avoid costly delays in global clinical trials by mastering regulatory compliance, coordinating logistics, and using tech to keep investigational therapies on schedule.

  7. Why Your QMS Is Failing (And How Predictive Analytics Can Save Your Next Audit) 3/16/2026

    Transform your QMS from reactive to proactive with predictive analytics that prevents deviations, streamlines audits, and keeps clinical trials on track.

  8. Choosing The Right Logistics Team For Complex Clinical Trials 3/3/2026

    Global trials demand more than shipping. Learn how IoR, EoR, cold chain control, and proactive logistics teams protect timelines, compliance, and patients.

  9. Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders, Part 2 2/25/2026

    FDA inspections are evolving. Equip your clinical supply team to manage on-site and remote audits with confidence and turn findings into stronger systems.

  10. Regulatory Readiness In Clinical Supply: Building A Culture Of Compliance, Part 1 2/24/2026

    FDA scrutiny is intensifying. Strong SOPs, airtight IP accountability, and data integrity practices are now essential to protect trials, patients, and approvals.